Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T18:56:15.072Z.
Calculation as of: 2026-10-06T18:56:15.072Z.
Quote observation: 2026-10-06T18:55:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6abed0f02887b3ac62520bc322e243c8ff06f4fcddd7c97914d2a236e2670171
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$321.48M
EV/FCF Ratio
78.73x
TTM Avg
888.92x
3Y Avg
1690.44x
5Y Avg
1690.44x
Market Cap
$315.23M
EV/FCF Ratio
N/A
TTM Avg
114948.95x
3Y Avg
114948.95x
5Y Avg
114948.95x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ClearPoint Neuro, Inc. (CLPT) | $324.75M | N/A | N/A | N/A | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $325.29M | N/A | N/A | N/A | N/A |
| Sanara MedTech Inc. (SMTI)vs › | $321.48M | 78.73x | 888.92x | 1690.44x | 1690.44x |
| CapsoVision, Inc. (CV)vs › | $326.98M | N/A | N/A | N/A | N/A |
| Avita Medical Inc. (RCEL)vs › | $319.48M | N/A | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $315.23M | N/A | 114948.95x | 114948.95x | 114948.95x |
| C4 Therapeutics, Inc. (CCCC)vs › | $313.46M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | N/A | N/A | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.23M | N/A | N/A | N/A | N/A |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $297.41M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute